Cineverse (CNVS) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
10 Aug, 2026Executive summary
Special Meeting scheduled for September 15, 2026, to vote on key proposals related to share issuance and meeting adjournment.
Proposals include approval for issuing Class A common stock for the IndiCue acquisition and convertible notes, and potential adjournment to solicit more proxies.
Virtual meeting format adopted for accessibility and cost efficiency.
Voting matters and shareholder proposals
Proposal 1 seeks approval to issue shares for the IndiCue acquisition and convertible note conversions, as required by Nasdaq Listing Rule 5635(a) and (d).
Proposal 2 requests authorization to adjourn the meeting if more time is needed to gather votes for Proposal 1.
Both proposals require a majority of votes cast for approval; abstentions and broker non-votes count as votes against.
No appraisal or dissenters' rights are available for these proposals.
Deadlines for shareholder proposals for the 2026 Annual Meeting are specified, with detailed submission requirements.
Board of directors and corporate governance
Board unanimously recommends voting in favor of both proposals.
Directors, executive officers, and principal stockholders collectively own approximately 12.4% of outstanding Class A common stock.
No current directors, officers, or affiliates have an interest in the shares to be issued under the proposals.
Latest events from Cineverse
- Revenue up 175% year-over-year, cost savings and streaming growth drive positive outlook.CNVS
Q1 2027 - Approval sought for major share issuance tied to acquisition and notes, with dilution and control impacts.CNVS
Proxy filing - Q4 revenue up 67% year-over-year; 2027 guidance reaffirmed with strong acquisition synergies.CNVS
Q4 2026 - Registering 21.8M shares for resale, with proceeds from warrants to fund growth and content.CNVS
Registration Filing - Revenue down 60% year-over-year; FY27 guidance boosted by accretive acquisitions.CNVS
Q3 2026 - Q2 revenue up 20% (ex-digital cinema); Terrifier 3 to drive major future profit gains.CNVS
Q2 2025 - Revenue fell 30% but margins, viewership, and future sales pipeline all improved.CNVS
Q1 2025 - Adjusted EBITDA rose to $4.4M on cost cuts, margin gains, and new channel growth.CNVS
Q4 2024 - Record revenue and net income, zero debt, and strong growth driven by Terrifier 3.CNVS
Q3 2025